Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer.
Ontology highlight
ABSTRACT: Lethal giant larvae homolog 2 (LLGL2) and solute carrier family 7 member 5 (SLC7A5) have been reported to be involved in resistance to endocrine therapy. This study aimed to assess the effects of LLGL2/SLC7A5 co-expression in predicting prognosis and response to tamoxifen therapy in ERα-positive breast cancer patients according to LLGL2/SLC7A5 mRNA and protein expression in long-term follow-up invasive breast cancer tissues. We identified that low LLGL2/SLC7A5 mRNA co-expression (LLGL2low/SLC7A5low) was associated with disease-free survival (DFS) compared with other combination groups in all breast cancer patients. In ERα-positive breast cancer patients, LLGL2low/SLC7A5low showed longer DFS and overall survival (OS) compared with LLGL2high</
SUBMITTER: Hisada T
PROVIDER: S-EPMC9529905 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA